1 / 5

North America Molecular Diagnostics Market Share, Industry Growth And Overview To 2024: Hexa Reports

The North America molecular diagnostics market is expected to reach over USD 7.2 billion by 2024, according to a new report by Grand View Research, Inc. As a developed economy, North America has a well-equipped healthcare infrastructure. Moreover, the U.S. healthcare expenditure is projected to increase at a substantial rate over the forecast period.

HexaReport
Download Presentation

North America Molecular Diagnostics Market Share, Industry Growth And Overview To 2024: Hexa Reports

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Hexa Reports Market Research Reports and Insightful Company Profiles North America Molecular Diagnostics Market Analysis, Share and Size, Trends, Industry Growth, Overview And Segment Forecasts To 2024 The North America molecular diagnostics market is expected to reach over USD 7.2 billion by 2024, according to a new report by Grand View Research, Inc. As a developed economy, North America has a well-equipped healthcare infrastructure. Moreover, the U.S. healthcare expenditure is projected to increase at a substantial rate over the forecast period. Technological advancement in molecular diagnostic kits is expected to serve the as a primary driving force. Extensive R&D activities undertaken by the major companies for expansion of their product portfolio is another factor supporting growth. For instance, in 2015, a strategic collaboration was made between Sysmex Corporation and Laboratory Corporation in the field of blood-based molecular diagnostic tests to develop precision medicine in oncology. Browse Detail Report With TOC @ http://www.hexareports.com/report/north-america-molecular-diagnostics-market/details Further key findings from the report suggest: Reagents dominated the molecular diagnostics market with revenue of over USD 1.0 billion in 2015, owing to increasing R&D initiatives and as a result of discovery of novel biomarkers for cancer. Moreover, the fastest growing segment over the forecast period is also expected to be reagents, due to increasing adoption in the process of drug discovery.

  2. Hexa Reports Market Research Reports and Insightful Company Profiles In 2015, the largest shareholder by test location was central laboratories with around 60.0% share. The key attributes included expansion of healthcare facilities and presence of multiple clinical laboratory assays. However, the point-of-care (PoC) segment is estimated to witness the most lucrative growth over the forecast period owing to development of fast and accurate diagnostic devices. Infectious diseases contributed to the largest market revenue in 2015, as a result of new product development in the field of blood screening tests. HIV served as the largest market share rendering segment among infectious diseases. The oncology segment is expected to grow at a lucrative double digit CAGR in the forecast period. This results from the high prevalence of cancer and greater opportunities in the field of cancer diagnostic tests for major players in North America. On the basis of technology, polymerase chain reaction (PCR) dominated the market with USD 1.2 billion in 2015, owing to increasing applications of PCR in cancer tests Request A Sample copy of This Report @ http://www.hexareports.com/sample/159391 Sequencing is anticipated to be the fastest growing technology over the forecast period due to introduction of cost-effective and quick next-generation sequencing platforms for genetic diseases, cancer, and other chronic disorders. The U.S. held the major share of the market in 2015 attributable to its developed economy and greater level of awareness amongst the population. However, Canada is estimated to exhibit the fastest growth in terms of CAGR, owing to increasing prevalence of lifestyle diseases, such as cardiovascular diseases. Some key players in the market include Abbott Laboratories; Roche Diagnostics; Hologic, Inc. (Gen Probe); Novartis AG; Bio-Rad laboratories, Inc.; Cepheid; Siemens Healthineers GmbH; Johnson & Johnson Services, Inc.; Bayer AG; Alere; bioMerieux SA; Sysmex Corporation; Becton, Dickinson and Company (BD); Danaher Corporation; Dako; and QIAGEN. The strategies implemented by the participants include innovations through introduction of devices providing quick test results of blood samples and expansion to emerging markets. Table Of Content Chapter 1 Executive Summary

  3. Hexa Reports Market Research Reports and Insightful Company Profiles Chapter 2 North America Molecular Diagnostics - Industry Outlook 2.1 Introduction 2.2 Market Segmentation 2.3 Market Size and Growth Prospects 2.4 Molecular Diagnostics - Market dynamics 2.5 Key Opportunities Prioritized 2.6 Molecular Diagnostics - PESTEL Analysis 2.7 Molecular Diagnostics Market - Company Market Share Analysis, 2013 Chapter 3 North America Molecular Diagnostics Product Outlook 3.1 Molecular Diagnostics Revenue Share by Product, 2013 & 2024 3.2 Molecular Diagnostic Instruments Market 3.3 Molecular Diagnostic Reagents Market 3.4 Others Healthcare Market Research Related Reports: Tuberculosis Diagnostics Market Size And Forecast And Trend Analysis From 2013 to 2024 - http://www.hexareports.com/report/tuberculosis-diagnostics-market/details Biosimulation Market Analysis And Segment Forecasts To 2024 - http://www.hexareports.com/report/biosimulation-market/details Chapter 4 North America Molecular Diagnostics Test Location Outlook 4.1 Molecular Diagnostics Revenue Share by Test Location, 2013 & 2024 4.2 Molecular Diagnostic Point-of-Care Market 4.3 Molecular Diagnostics Self-Test or OTC Market 4.4 Molecular Diagnostic Central Laboratories Market Chapter 5 North America Molecular Diagnostics Technology Outlook 5.1 Molecular Diagnostics Revenue Share by Technology, 2013 & 2024 5.2 Molecular Diagnostics Polymerase Chain Reaction (PCR) Market 5.3 Molecular Diagnostics In-situ Hybridization Market 5.4 Molecular Diagnostics Isothermal Nucleic Acid Amplification Technology (INAAT) Market 5.5 Molecular Diagnostics Chips and Microarrays Market 5.6 Molecular DIAGNOSTICS MASS SPECTROMETRY (MS) Market 5.7 Molecular Diagnostic Sequencing Market 5.8 Molecular Diagnostics Transcription Mediated Amplification (TMA) Market 5.9 Molecular Diagnostic Other Technology Segments Market

  4. Hexa Reports Market Research Reports and Insightful Company Profiles Chapter 6 North America Molecular Diagnostics Application Outlook 6.1 Molecular Diagnostics Revenue Share, by Application, 2013 & 2024 6.2 Molecular Diagnostics-based Oncology Market 6.3 Molecular Diagnostic-based Pharmacogenomics Market 6.4 Molecular Diagnostics-based Infectious Diseases Market 6.5 Molecular Diagnostics-based Genetic Testing Market 6.6 Molecular Diagnostics-based Neurological Diseases Market 6.7 Molecular Diagnostics-based Cardiovascular Diseases Market 6.8 Molecular Diagnostics-Microbiology Market 6.9 Molecular Diagnostics in Other Application Segments Market Chapter 7 North America Molecular Diagnostics Regional Outlook 7.1 North America Molecular Diagnostics Revenue Share by Region, 2013 & 2024 7.2 U.S. 7.3 Canada Chapter 8 Competitive Landscape 8.1 Abbott Laboratories 8.2 Alere 8.3 Bayer AG 8.4 BD 8.5 bioMérieux SA 8.6 Bio-Rad Laboratories ? 8.7 Cepheid 8.8 Dako 8.9 Danaher Corporation 8.10 Hologic, Inc. (Gen Probe) Chapter 9 Methodology and Scope 9.1 Research Methodology 9.2 Research Scope & Assumptions 9.3 List of Data Sources Browse Full Report @ http://www.hexareports.com/report/north-america-molecular-diagnostics-market/details About Us: Hexa Reports is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive

  5. Hexa Reports Market Research Reports and Insightful Company Profiles business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives. Contact Information: Ryan Shaw Felton Office Plaza, 6265 Highway 9, Felton, California, 95018, United States Phone Number 1-800-489-3075 Email Us: sales@hexareports.com Our Website: http://www.hexareports.com/ Visit our Blog: http://hexareports.blogspot.com/ Like our Facebook page: https://www.facebook.com/hexareportsindustry/ Follow us on LinkedIn: https://www.linkedin.com/company/hexa-reports-inc-

More Related